Home / Events / Generating Robust Insights to Develop a Compelling Value Story


Generating Robust Insights to Develop a Compelling Value Story

Available On Demand

The unprecedented availability of rich RWE data sources gives HEOR, V&A and medical leaders the opportunity to be more intentional than ever before. High-quality, compelling evidence is now a necessity, not just for high-value therapies playing in the rare disease space—but also more broadly, to show reduced unmet needs, HCRU and cost offsets. Deep experience using industry-leading data sources, tech-enabled methodologies and therapeutic expertise allow Trinity experts to choose the right data for each client situation and create foundational analyses today that will continue to support your questions in the future and drive downstream publications.

Come join Matt O’Hara, a Partner in Trinity’s Evidence Strategy practice, as he hosts a lively discussion featuring panelists Clare Gora, Vice President and Head of Analytics Client Development, and Jeff Skaar, a Managing Director in Trinity’s Evidence Strategy practice, who will share perspectives on RWE in HEOR.

Key Webinar Topics

  • Which data sources have the greatest utility for each specific TA and type of asset?
  • How—and when—can they be leveraged pre- and post-launch?
  • How should disparate data sources be linked / combined to maximize insights?
  • How to maximize your ROI on data acquisition and RWE insights?


Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.